Patents by Inventor Juan Ramon De Los Toyos Gonzalez

Juan Ramon De Los Toyos Gonzalez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas
    Patent number: 9702879
    Abstract: The present invention relates to in vitro methods and products for detecting the presence of an invasive carcinoma in an individual, for determining and/or predicting the stage and/or invasiveness of said carcinoma in an individual, or for monitoring the effect of the therapy administered to an individual who has said carcinoma based on col11a1 gene and proCOL11A1 protein expression. The invention also relates to the search for, identification, development and evaluation of the efficacy of compounds for therapy for said carcinoma, for the purpose of developing new medicinal products. The invention also relates to agents inhibiting proCOL11A1 protein expression and/or activity, and/or the effects of this expression.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: July 11, 2017
    Assignee: Oncomatryx Biopharma, S.L.
    Inventors: Luis Barneo Serra, Carmen Garcia Pravia, Juan Ramon De Los Toyos Gonzalez, Marcos Garcia Ocana, Jose Fernando Vazquez Villa, Nelson Fuentes Martinez, Jokin Del Amo Iribarren, Laureano Simon Buela
  • METHODS AND PRODUCTS FOR IN VITRO DIAGNOSIS, IN VITRO PROGNOSIS AND THE DEVELOPMENT OF DRUGS AGAINST INVASIVE CARCINOMAS
    Publication number: 20150362496
    Abstract: The present invention relates to in vitro methods and products for detecting the presence of an invasive carcinoma in an individual, for determining and/or predicting the stage and/or invasiveness of said carcinoma in an individual, or for monitoring the effect of the therapy administered to an individual who has said carcinoma based on col11a1 gene and proCOL11A1 protein expression. The invention also relates to the search for, identification, development and evaluation of the efficacy of compounds for therapy for said carcinoma, for the purpose of developing new medicinal products. The invention also relates to agents inhibiting proCOL11A1 protein expression and/or activity, and/or the effects of this expression.
    Type: Application
    Filed: August 8, 2012
    Publication date: December 17, 2015
    Inventors: Luis Barneo Serra, Carmen Garcia Pravia, Juan Ramon De Los Toyos Gonzalez, Marcos Garcia Ocana, Jose Fernando Vazquez Villa, Nelson Fuentes Martinez, Jokin Del Amo Iribarren, Laureano Simon Buela